Pharmaceutical behemoth Eli Lilly will slash the cost of its popular insulin products, relieving some of the financial burden on millions of Americans with .
The company said Tuesday that it will cut prices of its Humalog and Humulin injections, its two best-selling insulin products, by 70 percent in the fourth quarter.
And starting May 1, the company will lower the list price of unbranded insulin from $82 per vial to $25 per vial, the lowest level for insulin that diabetics take at mealtimes and less than the price of a Humalog vial in 1999.
Load More
Yorumlar
Kalan Karakter: